ArticleCerebellum (London, England)2022

PD-1-inhibitor-induced PCA-2 (MAP1B) Autoimmunity in a Patient with Renal Cell Carcinoma.

Yahel Segal et al.PubMed ↗Publisher ↗

No numbers read from the abstract.